Clinical Trials Sponsored by Eurofarma Laboratorios S.A.

Total 296 results

Eurofarma Laboratorios S.A.

Not yet recruiting

Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage

Skin Care

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil (FORASMA)

Moderate Asthma

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil (ALERZIN)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar Extraction (OXIFEN)

Pain

Brazil
Eurofarma Laboratorios S.A.

Active, not recruiting

Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)

Alopecia

Brazil
Eurofarma Laboratorios S.A.

Completed

UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit. (HEPIRC)

Hemodialysis Complication
Eurofarma Laboratorios S.A.

Completed

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL) (GLACIAL)

Osteoarthritis of Knee

Brazil
Eurofarma Laboratorios S.A.

Completed

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

Mild to Moderate Persistent Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab (NICAP)

Carcinoma | Head and Neck Cancer

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease (PANDA)

Gastroesophageal Reflux Disease

Brazil
Eurofarma Laboratorios S.A.

Completed

A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

Asthma

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma (UNIK)

Asthma

Brazil
Eurofarma Laboratorios S.A.

Unknown

Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension (CARD)

Arterial Hypertension

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Fixed Dose Combination of DESloratadine / PREDnisolone in the Treat. of Moderate - Severe Allergic Rhinitis in Children (DESPRED)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity (TOLERASIT)

Obesity | Overweight

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight (UNLIMITED)

Obesity | Overweight

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar Extraction (CODI)

Pain

Brazil
Eurofarma Laboratorios S.A.

Recruiting

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment (ESPIRE)

Asthma Copd

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Advanced Prostate Cancer

India
Eurofarma Laboratorios S.A.

Withdrawn

A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study (SAVE)

Knee Osteoarthritis
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis (RINEX50)

Rhinitis, Allergic, Perennial

Brazil
Eurofarma Laboratorios S.A.

Completed

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) (EVOLUTION)

Diabetes Mellitus, Type 2

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol

Metrorrhagia

Brazil
Eurofarma Laboratorios S.A.

Completed

Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations

Healthy | Neutropenia

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea (ACROSS)

Antibiotics

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Gastroesophageal Reflux Disease

Brazil
Eurofarma Laboratorios S.A.

Terminated

Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation (VECOR)

Unstable Angina | Non ST Segment Elevation Myocardial Infarction

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Adenocarcinoma | Carcinoma | Uterine Cervix Adenosquamous Carcinoma

Brazil
Eurofarma Laboratorios S.A.

Completed

A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer (NICE)

Adenocarcinoma | Esophageal Cancer

Brazil
Eurofarma Laboratorios S.A.

Terminated

A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery (HEP-SC)

Hip Fracture Surgery

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) (EF099)

Hypolactasia

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) (TRIPLAR)

Chronic Obstructive Pulmonary Disease

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Evaluation of the Protection of a Liquid Bandage

Skin Care

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment (RESFRIN)

Cold | Flu Symptom

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine

Migraine

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer

Breast Cancer

India
Eurofarma Laboratorios S.A.

Withdrawn

Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil (BENCOX)

Third Molar Extraction

Brazil
Eurofarma Laboratorios S.A.

Completed

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee (Artico)

Osteoarthritis of the Knee

Brazil
Eurofarma Laboratorios S.A.

Terminated

Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema

Congestive Heart Failure

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis (RINEX32)

Rhinitis, Allergic, Perennial

Brazil
Eurofarma Laboratorios S.A.

Unknown

The Effect of a Multivitamin in the Treatment of Memory Loss in Postmenopausal Women

Memory Disorders | Postmenopausal Symptoms

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy

Breast Cancer
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago

Acute Lumbago

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia (Eszo)

INSOMNIA

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI) (CECI)

Cystitis
Eurofarma Laboratorios S.A.

Completed

Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis (NOEX)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Neutropenia in Breast Cancer

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia (LAILAII)

Lactose Intolerance

Brazil
Eurofarma Laboratorios S.A.

Completed

Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain (Dextra)

Lumbar Sciatic Pain

Brazil
Eurofarma Laboratorios S.A.

Completed

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients With Asthma (CAINAS SF)

Asthma

Brazil

3

Subscribe